A common asthma pill… Singulair (montelukast); may help restore immunotherapy response in cancers that have stopped responding. Northwestern researchers discovered tumors exploit a molecule called CysLTR1 to evade treatment. #TCSC #CancerResearch #Oncology medicalxpress.com/news/2026-05...

After chemo, some cancer cells don’t die; they become “zombie cells” that make tumors more aggressive. Scientists at Imperial College London found new drugs that destroy them. In mice, tumors shrank and survival improved. #TCSC #CancerResearch #Oncology www.sciencedaily.com/releases/202...

Vicky Stinson was told she had months, not years, to live after a stage 3 pancreatic cancer diagnosis. Two years later, she’s hiking and painting watercolors and says she’s “not taking that prognosis.” #TCSC #CancerSurvivor www.npr.org/2026/05/12/n...

Glioblastoma has defeated nearly every treatment thrown at it for 20+ years. A new McMaster CAR T cell therapy may change that; eliminating tumors AND dismantling the support structure that lets them grow back. #TCSC #BrainCancer #CancerResearch medicalxpress.com/news/2026-05...

A single podcast appearance by Mel Gibson doubled ivermectin prescriptions in cancer patients; with no clinical trial evidence it works. Among patients with cancer, rates rose 2.5x. Doctors warn it could delay life-saving treatment. #TCSC #CancerCare #CancerNews www.healthday.com/health-news/...

Precision oncology reaches a rare cancer: the FDA just approved zenocutuzumab (Bizengri); the first targeted therapy for NRG1 fusion-positive bile duct cancer. #TCSC #CancerResearch #Oncology #RareCancer www.fda.gov/drugs/resour...

Historic FDA approval: vepdegestrant (Veppanu) is the first-ever PROTAC protein-degrader drug cleared for breast cancer. Unlike older therapies that block cancer proteins, this one destroys them completely. #TCSC #BreastCancer #CancerResearch #Oncology www.oncnursingnews.com/view/vepdege...

Survival is only part of the battle. MD Anderson is now trialing psilocybin-assisted therapy to help cancer patients overcome anxiety and depression during long-term treatment. Treating the whole person matters. #TCSC #CancerCare #Oncology #CancerResearch www.curetoday.com/view/clinica...

In 1995, Mel Mann was given 3 years to live after a leukemia diagnosis. He’s now 69 and training for his next marathon. The drug that saved him, Gleevec, just marked 25 years since FDA approval. Targeted therapy changed everything. #TCSC #CancerSurvivor #CancerResearch www.npr.org/2026/05/10/n...

For the first time ever, 7 in 10 people diagnosed with cancer can expect to live at least 5 years. The American Cancer Society says 4.8 million deaths have been avoided since 1991. Progress is real. #TCSC #CancerResearch #CancerSurvivor #Oncology www.curetoday.com/view/cancer-...

Lung cancer survivor Stephen Huff said biomarker testing “is the single most important thing that kept me alive.” Yesterday, the Tennessee governor signed a bill expanding coverage of that testing; a win Huff helped make happen. #TCSC #CancerSurvivor #CancerNews www.wsmv.com/2026/05/08/g...

Cancer care shouldn’t depend on your zip code. UPMC Hillman just launched Pluvicto… precision radiopharmaceutical therapy for metastatic prostate cancer; at a rural PA location, so patients no longer have to travel hours to Pittsburgh. #TCSC #ProstateCancer #CancerCare www.upmc.com/media/news/0...

Warning for cancer patients: biotin supplements taken for chemo hair loss may distort key blood test results; potentially masking recurrence or changing treatment plans. Ohio State researchers say talk to your oncologist first. #TCSC #CancerCare #CancerNews www.sciencedaily.com/releases/202...

Full House star Dave Coulier is in remission from TWO cancers; but is opening up about the brutal reality of treatment. Radiation left him unable to eat solid food for months and he lost 45 pounds. #TCSC #CancerSurvivor #CancerAwareness #NonHodgkinLymphoma variety.com/2026/tv/news...

New data from Memorial Sloan Kettering confirms what the RASolute 302 trial showed: daraxonrasib nearly doubles survival in metastatic pancreatic cancer as a second-line oral therapy. #TCSC #PancreaticCancer #CancerResearch #Oncology www.onclive.com/view/daraxon...

History made: the FDA has approved vepdegestrant (Veppanu); the world’s first PROTAC protein-degrader drug — for ER+/HER2-, ESR1-mutated advanced breast cancer. #TCSC #BreastCancer #CancerResearch #Oncology news.yale.edu/2026/05/07/y...

Against all odds; 15-year-old Will Roberts posted a video asking for help fighting a rare bone cancer. The internet responded. He has now started experimental treatment in California. This is what community looks like. #TCSC #CancerSurvivor #CancerNews #CancerResearch ktla.com/news/alabama...

Phase 3 results: combining the immune-modulatory cancer vaccine IO102-IO103 with pembrolizumab extended progression-free survival in untreated advanced melanoma; without significant added toxicity. #TCSC #Cancer #Oncology #MelanomaResearch www.cancertherapyadvisor.com/news/immune-...

A landmark moment for one of cancer’s hardest fights: an oral drug called daraxonrasib nearly doubled survival in metastatic pancreatic cancer vs standard chemo; 13.2 months vs 6.7 months. #TCSC #CancerResearch #PancreaticCancer #Oncology www.onclive.com/view/daraxon...

Good news for cancer patients in Northern Ireland: Keytruda’s one-minute injectable form is already being used across three health trusts; cutting treatment time by up to 90% and giving patients their time back. #TCSC #CancerNews #Immunotherapy #CancerResearch www.irishnews.com/news/norther...

New phase 3 data: adding the immune-modulatory vaccine IO102-IO103 to pembrolizumab appears to extend progression-free survival in treatment-naive advanced melanoma; without toxicity. Cancer vaccines are advancing fast. #TCSC #Oncology #MelanomaResearch www.cancertherapyadvisor.com/news/immune-...

Game-changer for cancer patients in England: a new subcutaneous pembrolizumab injection cuts treatment time from up to 2 hours down to just 60 seconds. 14 cancer types. 14,000 patients per year set to benefit. #TCSC #CancerNews #Oncology #NHS www.england.nhs.uk/2026/05/1-mi...

Against all odds; every single patient in a bowel cancer immunotherapy trial remains cancer-free nearly 3 years later. A short course of pembrolizumab before surgery produced zero relapses. This is what hope looks like. #TCSC #Cancer #CancerNews #Immunotherapy www.foxnews.com/health/patie...

ASCO 2026 preview: top Phase 3 immunotherapy trials include KEYLYNK-009 in cervical cancer, CheckMate 901 in bladder cancer, and SKYSCRAPER-01 in lung cancer. The data drops start June 1. oncodaily.com/science/7791... #ASCO2026 #Immunotherapy #CancerResearch #ClinicalTrials #TCSC

Scientists discovered why some breast cancers stop responding to hormone therapy: a gene called CDKN1B gets switched off; removing the brake on cancer cell growth. The fix? CDK4/6 inhibitors still work. www.nature.com/articles/s41... #BreastCancer #CancerResearch #Oncology #TCSC

Keytruda… one of the most powerful cancer immunotherapies; can now be delivered in 60 seconds. The NHS just rolled out a subcutaneous jab for 14 cancer types, cutting treatment time by up to 90%. www.england.nhs.uk/2026/05/1-mi... #Keytruda #NHS #CancerCare #Immunotherapy #TCSC

RP1 was given “breakthrough” designation. Expert panels recommended approval. The FDA rejected it twice anyway. Scientific American explains why; and it raises serious questions. www.scientificamerican.com/article/why-... #Melanoma #FDA #CancerPolicy #TCSC

FDA approved Veppanu; the first-ever PROTAC cancer drug, for advanced breast cancer with ESR1 mutations. A month ahead of schedule. A new class of medicine just crossed the finish line. www.fda.gov/drugs/resour... #BreastCancer #FDA #PROTAC #TCSC

Gordon was diagnosed with liver cancer. He got to MD Anderson within days, enrolled in an immunotherapy trial; and is now cancer-free. “I feel there has to be a reason why I was left here.” www.mdanderson.org/cancerwise/l... #LiverCancer #CancerSurvivor #Immunotherapy #ClinicalTrials #TCSC

A reminder that cancer desperation gets exploited. UK doctor Mohsen Ali was removed from the medical register after charging patients for unproven treatments at an unlicensed clinic. Know the warning signs. people.com/doctor-faces... #CancerScams #PatientSafety #CancerCare #TCSC

Pancreatic cancer patients have been pleading for access to daraxonrasib since the Phase 3 data dropped. The FDA listened; and acted in 48 hours. That speed matters when time is what patients don’t have. www.nytimes.com/2026/05/01/h... #PancreaticCancer #FDA #CancerHope #TCSC

BREAKING: The FDA approved expanded access for daraxonrasib; the pancreatic cancer drug that nearly doubled survival… just 2 days after receiving the request. Patients can now access it before full approval. www.fda.gov/news-events/... #PancreaticCancer #FDA #Daraxonrasib #TCSC

A simple blood test can now predict whether certain breast cancer patients will respond to immune-based therapy; before treatment even starts. No biopsy required. Published today in Science Translational Medicine. www.nature.com/articles/d41... #BreastCancer #PrecisionOncology #CancerResearch #TCSC

Activated T cells don’t just fight cancer themselves; they secrete tiny DNA-carrying capsules that can enter other immune cells and instruct them to join the fight. Published in Cancer Cell. newsroom.weill.cornell.edu/news/2026/04... #CancerImmunology #TCells #PancreaticCancer #CancerResearch #TCSC

In a world-first trial, T cells that behave like stem cells, able to self-renew and keep fighting long-term… produced complete remission in 5 of 11 blood cancer patients. Standard CAR-T achieved just 1 of 10. www.nature.com/articles/d41... #BloodCancer #CART #Leukemia #CancerResearch #TCSC

Up to 40% of cancer patients develop nerve damage! Numbness, tingling, pain in the hands and feet; from chemo. It’s one of the most under-discussed side effects. Here’s what to know… www.cancer.org/cancer/manag... #PeripheralNeuropathy #ChemotherapySideEffects #CancerCare #PatientSupport #TCSC

HPV-related head and neck cancers are on the rise; but so is the technology to treat them. Robotic surgery, targeted therapy; clinical trials are giving patients options that didn’t exist a decade ago. www.pennstatehealth.org/news/2026/04... #HeadAndNeckCancer #HPV #OncologyNews #CancerCare #TCSC

Nine weeks of immunotherapy before surgery. Zero cancer relapses after 33 months. That’s the result of the NEOPRISM-CRC trial for a specific type of bowel cancer; and it’s making waves at AACR 2026. scitechdaily.com/breakthrough... #BowelCancer #ColorectalCancer #Immunotherapy #AACR2026 #TCSC

Pfizer’s Elrexfio significantly improved progression-free survival vs standard care in a Phase 3 multiple #myeloma trial; and it’s already approved in over 35 countries. This result could expand who receives it and how early. www.reuters.com/business/hea... #BloodCancer #Oncology #Pfizer #TCSC

What if instead of flooding the whole body with immunotherapy, you injected it directly into the tumour? New Nature data shows that approach cut severe side effects in advanced skin cancer; and keep the treatment effective. www.nature.com/articles/d41... #SkinCancer #Melanoma #Immunotherapy #TCSC

No incision. No heat. No radiation. Histotripsy uses focused ultrasound waves to mechanically destroy liver tumours; then the body absorbs the debris naturally. FDA-cleared and now available in New Jersey. www.hackensackmeridianhealth.org/en/news/2026... #LiverCancer #CancerTreatment #Oncology #TCSC

Oncology trials have long measured success by how long patients survive. A new Lancet Oncology paper says that’s not enough; quality of life, time free from treatment burden & symptom control need to count too. www.eurekalert.org/news-release... #CancerResearch #ClinicalTrials #OncologyPolicy #TCSC

“We’ve turned a corner.” @PanCAN’s CEO watched her father die from pancreatic cancer with no options. This week, she stood at PurpleStride and said that era is ending. The data backs her up. pancan.org/news/the-tur... #PancreaticCancer #WageHope #TCSC

Getting a cancer diagnosis is devastating. Getting bad news delivered badly makes it worse. New ASCO guidelines on patient-clinician communication are trying to fix that! Dr. Timothy Gilligan explains! consultqd.clevelandclinic.org/getting-toug... #CancerCare #PatientCommunication #Oncology #TCSC

When cancer mutates, treatment has to mutate with it. One patient’s plan included brain radiation, lung radiation AND a targeted therapy; all tailored to different mutations in the same tumor. This is precision oncology! 6abc.com/post/moves-m... #PrecisionMedicine #CancerCare #OncologyNews #TCSC

Hot off the press: Erasca’s pan-RAS drug ERAS-0015 shrank tumours in 62% of lung cancer patients and 40% of pancreatic cancer patients. Phase 1 data released today. www.statnews.com/2026/04/27/e... #KRAS #LungCancer #PancreaticCancer #CancerResearch #TCSC

Given 3-4 months to live in December. Tumour volume down 76%. Pain down 80%. Former Sen. Ben Sasse says an experimental drug called daraxonrasib is why he’s still here. www.today.com/health/men-s... #PancreaticCancer #Daraxonrasib #CancerHope #TCSC

A new drug called setidegrasib doesn’t just block the KRAS cancer protein; it destroys it. First-in-human trial shows tumor shrinkage in lung & pancreatic cancers. Published today in the NEJM. www.uclahealth.org/news/release... #KRAS #LungCancer #PancreaticCancer #TCSC

Cancer incidence in younger adults is rising. They’re navigating diagnosis while building careers, starting families, and facing financial strain; without the support systems older patients often have. www.curetoday.com/view/rethink... #YoungAdultCancer #CancerCare #HealthEquity #TCSC

A cancer diagnosis shouldn’t mean the end of someone’s dream of having children; but without the right conversations early, it sometimes does. Patients need to ask about fertility preservation before treatment starts. www.curetoday.com/view/fertili... #CancerCare #Fertility #YoungAdultCancer #TCSC